Undersensing of ventricular fibrillation in a noncommitted nonthoracotomy cardioverter defibrillator system

PACE - Pacing and Clinical Electrophysiology

Volumn 20, Issue 3 I, 1997, Pages 610-618

  Peralta, Adelqui O ^a,b   John, Roy M ^a   Venditti Jr , Ferdinand J ^a   Martin, David T ^a  

^a LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^b Eleanor Naylor Dana Foundation   (United States)

Author keywords

defibrillation; implantable cardioverter defibrillators; undersensing

Indexed keywords

ADULT; ARTICLE; CARDIOVERSION; CLINICAL ARTICLE; DEFIBRILLATION; DEFIBRILLATOR; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HEART ELECTROPHYSIOLOGY; HEART VENTRICLE FIBRILLATION; HUMAN; IMPLANTATION; MALE;

CARDIAC PACING, ARTIFICIAL; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HUMANS; MALE; MIDDLE AGED; TIME FACTORS; VENTRICULAR FIBRILLATION;

EID: 0030899460     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8159.1997.tb03878.x     Document Type: Article

References (23)

1. Akhtar M, Jazayeri M, Sra J, et al. Implantable cardioverter defibrillator for prevention of sudden cardiac death in patients with ventricular tachycardia and ventricular fibrillation: ICD therapy in sudden cardiac death. PACE 1993; 16:511-518.
2. Powell AC, Fuchs T, Finkelstein DM, et al. Influence of implantable cardioverter-defibrillators on the long term prognosis of survivors of out of hospital cardiac arrest. Circulation 1993; 88: 1083-1092.
3. Kelly RA, Cannom DS, Garan H, et al. The automatic implantable cardioverter-defibrillator: Efficacy, complications, and survival in patients with malignant ventricular arrhythmias. J Am Coll Cardiol 1988; 11:1278-1286.
4. Nisam S, Mower M, Moser S. ICD clinical update: First decade, initial 10,000 patients. PACE 1991; 14:255-262.
5. Saksena S, Krol RB, Kaushik RR. Innovations in pulse generators and lead systems: Balancing complexity with clinical benefit and long term results. Am Heart J 1994; 127:1010-1021.
6. Bardy GH, Hofer B, Johnson G, et al. Implantable transvenous cardioverter-defibrillators. Circulation 1993; 87:1152-1168.
7. Manolis AS. Transvenous cardioverter defibrillator systems. Is the future here? Arch Intern Med 1994; 154:617-622.
8. Saksena S, and the PCD Investigators. Defibrillation thresholds and perioperative mortality associated with endocardial and epicardial defibrillation lead systems. PACE 1993; 16:202-207.
9. Schwartzman D, Gottlieb CD, Callans DJ, et al. Comparative effects of shocks on the endocardial rate-sensing signals from transvenous lead systems. (abstract) J Am Coll Cardiol 1995; 25(Suppl.):15A
10. Jung W, Manz M, Moosdorf R, et al. Failure of an implantable cardioverter-defibrillator to redetect ventricular fibrillation in patients with a nonthoracotomy lead system. Circulation 1992; 86: 1217-1222.
11. Herre JM, and the US Endotak Investigators. Detection and redetection characteristics of the Endotak C transvenous lead system. (abstract) Circulation 1993; 88(Suppl. I):I-154.
12. Berul CI, Callans DJ Schwartzman DS, et al. Comparison of initial detection and redetection of ventricular fibrillation in a transvenous defibrillator system with automatic gain control. J Am Coll Cardiol 1995; 25:431-436.
13. Hurwitz JL, Hook BG, Flores BT, et al. Importance of abortive shock capability with electrogram storage in cardioverter-defibrillator devices. J Am Coll Cardiol 1993; 21:895-900.
14. Singer I, Adams L, Austin E. Potential hazard of fixed gain sensing and arrhythmia reconfirmation for implantable cardioverter defibrillators. PACE 1993; 16:1070-1079.
15. Mann DE, Kelly PA, Damle RS, et al. Undersensing during ventricular tachyarrhythmias in a third-generation implantable cardioverter defibrillator: Diagnosis using stored electrograms and correction with programming. PACE 1994; 17: 1525-1530.
16. Venditti FJ Jr, Martin DT, Shahian D. The CPI Endotak nonthoracotomy lead system. In NAM Estes, AS Manolis, P Wang (eds.): Implantable Cardioverter-Defibrillators: A Comprehensive Textbook. New York, Marcel Dekker, Inc., 1994, pp. 779-794.
17. Venditti FJ Jr, Martin DT, Vassolas G, et al. Rise in chronic defibrillation threshold in non-thoracotomy implantable defibrillator. Circulation 1994; 89:216-223.
18. Callans DJ, Swarna US, Schwartzman D, et al. Postshock sensing performance in transvenous defibrillation lead systems: Analysis of detection and redetection of ventricular fibrillation. J Cardiovasc Electrophysiol 1995; 6:604-612.
19. Bardy GH, Ivey TD, Stewart R, et al. Failure of the automatic implantable defibrillator to detect ventricular fibrillation. Am J Cardiol 1986; 58: 1107-1108.
20. Ellis JR, Martin DT, Venditti FJ Jr. Appropriate sensing of ventricular fibrillation after failed shocks in a transvenous cardioverter-defibrillator system. Circulation 1994; 90:1820-1825.
21. Olson WH, Gillberg MS, and the Tachy Field Engineers. Reduced post-shock electrograms amplitudes and asynchronous pacing for ICD-Endotak combinations. (abstract) PACE 1994; 17(Pt. II):743.
22. Kerber RE, Sarnat W. Factors influencing the success of ventricular defibrillation in man. Circulation 1979; 60:226-230.
23. Winkle RA, Mead RH, Ruder MA, et al. Effect of duration of ventricular fibrillation on defibrillation efficacy in humans. Circulation 1990; 81: 1477-1481.